Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia.

about

Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia.

Item

http://www.wikidata.org/entity/Q36159786

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Safety and efficacy of liposom ...... hout HIV, North-West Ethiopia.

@ast

Safety and efficacy of liposom ...... hout HIV, North-West Ethiopia.

@en

type

Item

label

Safety and efficacy of liposom ...... hout HIV, North-West Ethiopia.

@ast

Safety and efficacy of liposom ...... hout HIV, North-West Ethiopia.

@en

prefLabel

Safety and efficacy of liposom ...... hout HIV, North-West Ethiopia.

@ast

Safety and efficacy of liposom ...... hout HIV, North-West Ethiopia.

@en

P1476

Safety and efficacy of liposom ...... hout HIV, North-West Ethiopia.

@en

P2093

Aschalew Tamiru

http://www.w3.org/2001/XMLSchema#string

Bethlehem Tigabu

http://www.w3.org/2001/XMLSchema#string

Ermias Diro

http://www.w3.org/2001/XMLSchema#string

Sisay Yifru

http://www.w3.org/2001/XMLSchema#string

P2860

Leishmaniasis worldwide and global estimates of its incidence

Single-dose liposomal amphotericin B for visceral leishmaniasis in India

Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial

Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial

Effectiveness and safety of liposomal amphotericin B for visceral leishmaniasis under routine program conditions in Bihar, India.

Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies.

The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination.

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.

Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.

Single-dose indigenous liposomal amphotericin B in the treatment of Indian visceral leishmaniasis: a phase 2 study

P2888

s12879-016-1746-1

P304

548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12879-016-1746-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Asrat Hailu

P577

2016-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1053639248

http://www.w3.org/2001/XMLSchema#string

P698

27724891

http://www.w3.org/2001/XMLSchema#string

P921

Ethiopia

visceral leishmaniasis

P932

5057416

http://www.w3.org/2001/XMLSchema#string